These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9222058)

  • 1. Evaluation of the resistance induction in enteric flora in children caused by oral ampicillin plus sulbactam.
    Soylu A; Sanlidag T; Türkmen M; Cakir N; Kavukçu S
    J Antimicrob Chemother; 1997 Jun; 39(6):833-5. PubMed ID: 9222058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escherichia coli resistant to ampicillin/sulbactam.
    Eng RH; Yen K; Smith SM; Citron DM; Goldstein EJ; Greenberg R; Cherubin CE
    Chemotherapy; 1992; 38(6):399-404. PubMed ID: 1288964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of sulbactam/ampicillin against ampicillin-resistant, beta-lactamase-producing bacteria isolated in Italian hospitals.
    Varaldo PE; Ripa S; Nicoletti G; Covelli I; Satta G; Carlone N; Fontana R
    Chemotherapy; 1990; 36(2):141-6. PubMed ID: 2178890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of ampicillin-sulbactam in an in vitro infection model against Escherichia coli strains with various levels of resistance.
    Lamp KC; Vickers MK
    Antimicrob Agents Chemother; 1998 Feb; 42(2):231-5. PubMed ID: 9527765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of sultamicillin on intestinal bacterial flora].
    Iwata S; Yamada K; Kin Y; Yokota T; Kusumoto Y; Sato Y; Akita H; Nanri S; Oikawa T; Sunakawa K
    Jpn J Antibiot; 1988 Dec; 41(12):2012-34. PubMed ID: 3266882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of TEM-1 β-Lactamase in the Predominance of Ampicillin-Sulbactam-Nonsusceptible
    Noguchi T; Matsumura Y; Kanahashi T; Tanaka M; Tsuchido Y; Matsumura T; Nakano S; Yamamoto M; Nagao M; Ichiyama S
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of effect of ampicillin-sulbactam against TEM-1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: enzyme activity versus MIC.
    Firsov AA; Saverino D; Ruble M; Gilbert D; Manzano B; Medeiros AA; Zinner SH
    Antimicrob Agents Chemother; 1996 Mar; 40(3):734-8. PubMed ID: 8851602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL; Monroy E; García O; Vaca S
    Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of antibacterial agents against clinical isolates of Escherichia coli and Klebsiella species from intensive care units.
    Gill CJ; Ponticas S; Shungu DL; Guerriero S
    Clin Ther; 1991; 13(1):25-37. PubMed ID: 2029725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic resistance in Australia with special reference to sulbactam/ampicillin.
    Fernandes CJ; Ackerman VP
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):153S-157S. PubMed ID: 2591174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of sultamicillin fine granules in pediatric infections].
    Meguro H; Arimasu O; Hiruma F; Sugie N; Nishimura S; Abe T; Fujii R; Mashiko J; Nagao Y; Okamoto Y
    Jpn J Antibiot; 1988 Dec; 41(12):1847-54. PubMed ID: 3249358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of resistance to anaerobic organisms in Australia.
    Munro R
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):159S-163S. PubMed ID: 2591175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A combination of ampicillin and sulbactam: effect on aerobic and anaerobic gram-negative bacteria].
    González C; García A; Urrea R; del Solar E; Bello H; Zemelman R
    Rev Med Chil; 1990 May; 118(5):548-54. PubMed ID: 2293275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactamase production and the role of ampicillin/sulbactam.
    Alpuche-Aranda CM
    Pediatr Infect Dis J; 1998 Mar; 17(3 Suppl):S8-11; discussion S20-1. PubMed ID: 9519908
    [No Abstract]   [Full Text] [Related]  

  • 16. Activity of sulbactam combinations against Escherichia coli isolates with known amounts of TEM-1 beta-lactamase.
    Livermore DM
    J Antimicrob Chemother; 1992 Feb; 29(2):222-4. PubMed ID: 1506339
    [No Abstract]   [Full Text] [Related]  

  • 17. [The inhibitor effect of the ampicillin-sulbactam combination on Enterobacteriaceae resistant to ampicillin].
    Poiată A; Diculencu D; Buiuc D
    Bacteriol Virusol Parazitol Epidemiol; 1992; 37(1-2):67-9. PubMed ID: 1472781
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacteriological studies with ampicillin/sulbactam on selected strains of gram-negative bacteria.
    Bello H; del Solar E; González C; Garcia A; Urrea R; Zemelman R
    Diagn Microbiol Infect Dis; 1988 Oct; 11(2):109-15. PubMed ID: 3067960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigallocatechin gallate synergy with ampicillin/sulbactam against 28 clinical isolates of methicillin-resistant Staphylococcus aureus.
    Hu ZQ; Zhao WH; Hara Y; Shimamura T
    J Antimicrob Chemother; 2001 Sep; 48(3):361-4. PubMed ID: 11533000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of beta-lactam drugs and sulbactam against Chlamydia trachomatis.
    Segreti J; Kapell KS; Trenholme GM
    Diagn Microbiol Infect Dis; 1992; 15(4):371-3. PubMed ID: 1611854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.